Cite
APA Citation
Bossuyt, P., Bresso, F., Dubinsky, M., Ha, C., Siegel, C., Zambrano, J., Kligys, K., Kalabic, J., Zhang, Y., & Panaccione, R. (n.d.). oP40 Efficacy of risankizumab induction and maintenance therapy by baseline Crohn's Disease location: Post hoc analysis of the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. Journal of Crohn's and colitis, 16, i048. http://access.bl.uk/ark:/81055/vdc_100150514992.0x000012